| Literature DB >> 34970506 |
Xiao-Song Wang1,2, Xi-Hai Xu2,3, Gang Jiang4, Yu-Huan Ling4, Tian-Tian Ye4, Yun-Wu Zhao2, Kun Li3, Yu-Ting Lei3, Hua-Qing Hu2, Ming-Wei Chen2, Heng Wang1,2.
Abstract
The prevalence of Helicobacter pylori infection is high worldwide, while numerous research has focused on unraveling the relationship between H. pylori infection and extragastric diseases. Although H. pylori infection has been associated with thyroid diseases, including thyroid nodule (TN), the relationship has mainly focused on potential physiological mechanisms and has not been validated by large population epidemiological investigations. Therefore, we thus designed a case-control study comprising participants who received regular health examination between 2017 and 2019. The cases and controls were diagnosed via ultrasound, while TN types were classified according to the guidelines of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). Moreover, H. pylori infection was determined by C14 urea breath test, while its relationship with TN type risk and severity was analyzed using binary and ordinal logistic regression analyses. A total of 43,411 participants, including 13,036 TN patients and 30,375 controls, were finally recruited in the study. The crude odds ratio (OR) was 1.07 in Model 1 (95% CI = 1.03-1.14) without adjustment compared to the H. pylori non-infection group. However, it was negative in Model 2 (OR = 1.02, 95% CI = 0.97-1.06) after being adjusted for gender, age, body mass index (BMI), and blood pressure and in Model 3 (OR = 1.01, 95% CI = 0.97-1.06) after being adjusted for total cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein on the basis of Model 2. Control variables, including gender, age, BMI, and diastolic pressure, were significantly correlated with the risk of TN types. Additionally, ordinal logistic regression results revealed that H. pylori infection was positively correlated with malignant differentiation of TN (Model 1: OR = 1.06, 95% CI = 1.02-1.11), while Model 2 and Model 3 showed negative results (Model 2: OR = 1.01, 95% CI = 0.96-1.06; Model 3: OR = 1.01, 95% CI = 0.96-1.05). In conclusion, H. pylori infection was not significantly associated with both TN type risk and severity of its malignant differentiation. These findings provide relevant insights for correcting possible misconceptions regarding TN type pathogenesis and will help guide optimization of therapeutic strategies for thyroid diseases.Entities:
Keywords: Helicobacter pylori; pathogenesis; population; risk; thyroid nodule
Mesh:
Year: 2021 PMID: 34970506 PMCID: PMC8713074 DOI: 10.3389/fcimb.2021.766427
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Participant characteristics.
| Characteristics | Total | TN types | Controls |
|
|---|---|---|---|---|
| Samples, n | 43,411 | 13,036 | 30,375 | – |
| Women, n | 18,096 | 6,625 | 11,471 | <0.001 |
| Age, years | 45.68 ± 14.08 | 52.64 ± 14.04 | 42.69 ± 13.00 | <0.001 |
| BMI, kg/m2 | 23.60 ± 3.25 | 23.85 ± 3.17 | 23.50 ± 3.27 | <0.001 |
| SP, mmHg | 126.37 ± 18.23 | 129.99 ± 19.61 | 124.81 ± 17.38 | <0.001 |
| DP, mmHg | 76.82 ± 11.95 | 77.82 ± 12.00 | 76.39 ± 11.91 | <0.001 |
| TCH, mmol/L | 4.65 ± 0.90 | 4.76 ± 0.95 | 4.60 ± 0.88 | <0.001 |
| TG, mmol/L | 1.61 ± 1.41 | 1.64 ± 1.48 | 1.59 ± 1.38 | <0.001 |
| LDL-C, mmol/L | 2.68 ± 0.79 | 2.76 ± 0.82 | 2.65 ± 0.77 | <0.001 |
| HDL-C, mmol/L | 1.38 ± 0.38 | 1.40 ± 0.39 | 1.37 ± 0.38 | <0.001 |
| 14 C-urea breath test, n (+) | 17,697 | 5,461 | 12,236 | 0.002 |
TN, thyroid nodule; BMI, body mass index; SP, systolic pressure; DP, diastolic pressure; TCH, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Figure 1The prevalence of TN types increased with age in both H. pylori (+) and H. pylori (-) groups. Among the five age ranges, only in the 50-59 years subgroup, the prevalence of TN types in the H. pylori (+) group was statistically lower than that in the H. pylori (-) group. However, in other age subgroups, no significant difference was found in the prevalence of TN types between H. pylori (+) and H. pylori (-) groups.
Figure 2The prevalence of TN types increased slowly with the increase of BMI. Among the four BMI ranges, only in the 18.5-23 kg/m2 subgroup, the prevalence of TN types in the H. pylori (+) group was statistically higher than that in the H. pylori (-) group, and no significant difference was found in the prevalence of TN types between H. pylori (+) and H. pylori (-) groups in other BMI subgroups
OR for the association between H. pylori infection and the risk of TN types.
| C14 test | TN types | Controls | Model 1 | Model 2 | Model 3 |
|---|---|---|---|---|---|
| n (%) | n (%) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
|
| 7,575 (58.1%) | 18,139 (59.7%) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
|
| 5,461 (41.9%) | 12,236 (40.3%) | 1.07 (1.03–1.14) | 1.02 (0.97–1.06) | 1.01 (0.97–1.06) |
|
| – | – | 0.002* | 0.505 | 0.597 |
Model 1: unadjusted; Model 2: adjusted for gender, age, BMI, systolic, diastolic; Model 3: Model 2 + adjusted for TCH, TG, LDL, HDL.
TN, thyroid nodule; C14 test, carbon-14 urea breath test; CI, confidence interval; BMI, body mass index; SP, systolic pressure; DP, diastolic pressure; TCH, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
*P value is considered statistically significant.
Subgroup analysis of H. pylori infection and the risk of TN types.
| Subgroups | Samples |
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|---|---|---|
| n (%) | TN types | Controls | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Gender | ||||||
| Male | 25,307 (58.3%) | 6,409 (49.2%) | 18,898 (62.2%) | 1.04 (0.98–1.10) | 1.01 (0.95–1.08) | 1.01 (0.95–1.07) |
| Female | 18,096 (41.7%) | 6,625 (50.8%) | 11,471 (37.8%) | 1.12 (1.05–1.20)* | 1.02 (0.96–1.10) | 1.02 (0.95–1.09) |
| Age | ||||||
| <30 | 5,753 (13.3%) | 635 (4.9%) | 5,118 (16.8%) | 1.13 (0.95–1.34) | 1.16 (0.97–1.39) | 1.19 (0.99–1.43) |
| 30–39 | 10,708 (24.7%) | 1,746 (13.4%) | 8,962 (29.5%) | 1.09 (0.98–1.21) | 1.10 (0.99–1.23) | 1.11 (0.99–1.24) |
| 40–49 | 10,475 (24.1%) | 3,070 (23.6%) | 7,405 (24.4%) | 1.05 (0.96–1.14) | 1.06 (0.97–1.16) | 1.04 (0.95–1.15) |
| 50–59 | 9,464 (21.8%) | 3,746 (28.7%) | 5,718 (18.8%) | 0.91 (0.94–0.99)* | 0.92 (0.85–1.01) | 0.92 (0.84–1.00) |
| ≥60 | 7,010 (16.1%) | 3,839 (29.4%) | 3,171 (10.4%) | 0.98 (0.89–1.08) | 0.96 (0.87–1.06) | 0.96 (0.87–1.06) |
| BMI | ||||||
| <18.5 | 1,710 (4.2%) | 372 (3.1%) | 1,338 (4.7%) | 1.10 (0.87–1.39) | 1.03 (0.80–1.33) | 0.99 (0.76–1.29) |
| 18.5–23 | 16,370 (40.2%) | 4,593 (37.7%) | 11,777 (41.3%) | 1.13 (1.05–1.21)* | 1.06 (0.98–1.14) | 1.06 (0.98–1.14) |
| 23–27.5 | 18,059 (44.4%) | 5,753 (47.2%) | 12,306 (43.2%) | 1.02 (0.96–1.09) | 0.98 (0.92–1.05) | 0.97 (0.90–1.04) |
| ≥27.5 | 4,557 (11.2%) | 1,464 (12.0%) | 3,093 (10.8%) | 1.06 (0.94–1.20) | 1.03 (0.90–1.18) | 1.05 (0.92–1.21) |
Model 1: unadjusted; Model 2: adjusted for gender, age, BMI, SP, and DP; Model 3: Model 2 + adjusted for TCH, TG, LDL, and HDL.
TN, thyroid nodule; CI, confidence interval; BMI, body mass index; SP, systolic pressure; DP, diastolic pressure; TCH, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
*P value is considered statistically significant.
Ordinal logistic regression analysis of the H. pylori infection and the severity of TN types.
| C14 test | The classification of TN types, n (%) | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|---|
| Negative | TI-RADS ≤ 2 | TI-RADS3 | TI-RADS≥4 | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
|
| 18,139 (59.7%) | 1,603 (56.2%) | 5,556 (58.8%) | 416 (57.1%) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
|
| 12,236 (40.3%) | 1,251 (43.8%) | 3,897 (41.2%) | 313 (42.9%) | 1.06 (1.02–1.11) | 1.01 (0.96–1.06) | 1.01 (0.96–1.05) |
|
| – | – | – | – | 0.005* | 0.695 | 0.848 |
Model 1: unadjusted; Model 2: adjusted for sex, age, BMI, systolic, diastolic; Model 3: Model 2 + adjusted for TCH, TG, LDL, and HDL.
TN, thyroid nodule; C14 test, carbon-14 urea breath test; CI, confidence interval; BMI, body mass index; SP, systolic pressure; DP, diastolic pressure; TCH, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
*P value is considered statistically significant.